Authors
From a newly synthesised tridentate ligand [pepci =N′-(2-pyridin-2-ylethyl)pyridine-2-carbaldimine] two new octahedrally co-ordinated nickel(II) dimers, [{Ni(pepci)(N3)2}2]1 and [{Ni(pepci)(NCS)2}2]2, have been prepared. The crystal structure 1 has been solved. It crystallizes in space group P21/c with four formula weights in a cell measuring a= 9.198(3), b= 17.382(6), c= 19.356(7)Å, and β= 99.57(1)°. The structure consists of isolated dimeric units in which the nickel ions are linked by two azide bridging groups in an end-on fashion. Two pepci ligands and two terminal azide groups complete the co-ordination spheres. Inside the dimer, each Ni(pepci)(N3)2 entity is crystallographically non-equivalent. There are two different bridging angles Ni(A)–N(4A)–Ni(B) 102.2(2) and Ni(B)–N(4B)–Ni(A) 101.0(2)°. The co-ordination geometry at each nickel atom is approximately octahedral. The Ni(A)⋯ Ni(B) distance is 3.297(1)Å. For complex 2 a dimeric structure involving end-to-end thiocyanate bridging groups is proposed. Magnetic susceptibility data, measured from 4 to 300 K, were fitted to the Ginsberg equation, giving the parameters (cm–1): J=+36.3, D=–18.8, z′J′= 0.0 (N3); and J=+4.9, D=–9.8, z′J′=+0.33 (NCS). The magnetic behaviour of these and related complexes is discussed and some magnetostructural trends are given.
No takes yet. Share an insight, caveat, or question.
Cortés et al. (1992) studied this question.
Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context: